Literature DB >> 10573137

Induction of beta-2-microglobulin release in vitro by chronic lymphocytic leukaemia cells: relation to total protein synthesis.

J Vilpo1, L Vilpo, M Hurme, P Vuorinen.   

Abstract

The in vitro production of beta2-M by B-CLL cells from 27 patients was investigated. In all cases, low spontaneous beta2-M release was observed. The production of beta2-M was enhanced to various extents when induced with 13 different stimulants and their combinations including IL-2, TNFalpha, SAC and TPA. Beta2-M release was 3.8-fold (range from 1.9 to 9.2-fold) in cultures stimulated with TPA (10 ng/ml), compared with the spontaneous release, and even faster if TNFalpha or IL-2 were added. A strong correlation was revealed between beta2-M production and the total protein synthesis of leukaemic cells when the latter was assessed using 14C-L-leucine incorporation. Hence, both beta2-M release and leucine incorporation are promising activation markers for CLL B-lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10573137     DOI: 10.1016/s0145-2126(99)00109-5

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  4 in total

1.  Predictive value of beta2-microglobulin (beta2-m) levels in chronic lymphocytic leukemia since Binet A stages.

Authors:  Massimo Gentile; Giovanna Cutrona; Antonino Neri; Stefano Molica; Manlio Ferrarini; Fortunato Morabito
Journal:  Haematologica       Date:  2009-06       Impact factor: 9.941

2.  Venous thromboembolism in chronic lymphocytic leukemia: a Danish nationwide cohort study.

Authors:  Inger Lise Gade; Signe Juul Riddersholm; Ilse Christiansen; Annika Rewes; Mikael Frederiksen; Lisbeth Enggaard; Christian Bjørn Poulsen; Olav Jonas Bergmann; Dorte Balle Gillström; Robert Schou Pedersen; Linda Nielsen; Helle Højmark Eriksen; Christian Torp-Pedersen; Søren Risom Kristensen; Marianne Tang Severinsen
Journal:  Blood Adv       Date:  2018-11-13

3.  Long-term follow-up of patients receiving allogeneic stem cell transplant for chronic lymphocytic leukaemia: mixed T-cell chimerism is associated with high relapse risk and inferior survival.

Authors:  Philip A Thompson; Francesco Stingo; Michael J Keating; William G Wierda; Susan M O'Brien; Zeev Estrov; Celina Ledesma; Katayoun Rezvani; Muzaffar Qazilbash; Nina Shah; Simrit Parmar; Uday Popat; Paolo Anderlini; Nieto Yago; Stefan O Ciurea; Partow Kebriaei; Richard Champlin; Elizabeth J Shpall; Chitra M Hosing
Journal:  Br J Haematol       Date:  2017-03-14       Impact factor: 6.998

4.  β2 -microglobulin normalization within 6 months of ibrutinib-based treatment is associated with superior progression-free survival in patients with chronic lymphocytic leukemia.

Authors:  Philip A Thompson; Susan M O'Brien; Lianchun Xiao; Xuemei Wang; Jan A Burger; Nitin Jain; Alessandra Ferrajoli; Zeev Estrov; Michael J Keating; William G Wierda
Journal:  Cancer       Date:  2015-11-20       Impact factor: 6.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.